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The T-cell receptor  (TCR)/pre-TCR
(pT) pre-TCR complex (pre-TCR) signals
the expansion and differentiation of de-
veloping thymocytes. Functional pro-
perties of the pre-TCR rely on its unique
pT chain, which suggests the participa-
tion of specific intracellular adaptors.
However, pT-interacting molecules re-
main unknown. Here, we identified a
polyproline-arginine sequence in the hu-
man pT cytoplasmic tail that interacted
in vitro with SH3 domains of the CIN85/
CMS family of adaptors, and mediated the
recruitment of multiprotein complexes
involving all (CMS, CIN85, and CD2BP3)
members. Supporting the physiologic rel-
evance of this interaction, we found that
1 such adaptor, CMS, interacted in vivo
with human pT, and its expression was
selectively up-regulated during human
thymopoiesis in pre-TCR–activated thy-
mocytes. Upon activation, pre-TCR clus-
tering was induced, and CMS and poly-
merized actin were simultaneously
recruited to the pre-TCR activation site.
CMS also associated via its C-terminal
region to the actin cytoskeleton in the
endocytic compartment, where it colocal-
ized with internalized pT in traffic to
lysosomal degradation. Notably, deletion
of the pT CIN85/CMS-binding motif im-
paired pre-TCR–mediated Ca2 mobiliza-
tion and NFAT transcriptional activity, and
precluded activation induced by overex-
pression of a CMS-SH3 N-terminal mu-
tant. These results provide the first
molecular evidence for a pT intracellular
adaptor involved in pre-TCR function.
(Blood. 2007;110:4331-4340)
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Introduction
Intrathymic differentiation of  T lymphocytes is a complex
process regulated at 2 consecutive checkpoints through the pre–T-
cell receptor (TCR) and the  TCR.1,2 Surface expression of the
TCR –pre-TCR (pT) pre-TCR heterodimer (pre-TCR) signals
the expansion and further differentiation of developing pre-T cells,
a process called -selection.3-5 Thereafter, replacement of the
pre-TCR by the mature TCR allows for positive and negative
selection of developing thymocytes.1,2
The similar biochemical composition of the pre-TCR and the
TCR initially supported the view that pT is simply a “surro-
gate” TCR chain. However, pT and TCR are not interchange-
able partners of TCR during T-cell development.6,7 Rather, the
pT molecule endows the pre-TCR with unique functional proper-
ties, such as constitutive clustering and ligand-independent activa-
tion,5,8-11 which likely occur through oligomerization mediated by
the pT extracellular (EC) domain.12 Other pT structural features
that could account for the unique functional properties of the
pre-TCR rely on the presence of a long cytoplasmic tail that could
mediate pre-TCR signaling. However, despite being highly con-
served at the EC and transmembrane (TM) domains, mouse and
human pT differ significantly at the cytoplasmic (CT) domain
(30 and 114 amino acids, respectively). This difference, together
with experimental data in mice, initially diminished the functional
relevance of the pT CT domain.13,14 In contrast, the human pT
CT domain was shown to serve an endoplasmic reticulum retention
function that regulated pre-TCR assembly and expression.15 More-
over, constitutive pre-TCR internalization and degradation16,17 was
also dependent on the pT CT domain in humans.16 Despite these
initial discrepancies, more recent data have pointed to an essential
and previously unappreciated functional role for the CT tail of pT
also in mice, since the C-terminal (C-term) portion of murine pT
was proved to be crucial for intrathymic development.18 What
exactly the pT CT domain does to promote pre-TCR signaling
remains an open question, but proper pre-TCR function seems to
require the contribution of 2 proline-rich sequences present in its
C-term portion.18 It is thus likely that polyproline sequences within
the pT tail directly interact with molecules that could propagate
signals emanating from the pre-TCR. Therefore, the characteriza-
tion of those intracellular adaptors would be essential to understand
the basis of the unique signaling properties of the pre-TCR.
However, proteins that associate with the pT cytoplasmic domain
have not been identified as yet.
The proline-rich tandem repeat (PPTHR and PPSRK) present
within the murine pT CT domain is conserved as a single
sequence (PPGRK) in humans.4 Although different from the
consensus PXXP or PPLP SH3-binding motifs, this sequence
displays some homology with 2 tandem PPGHR sequences within
the CT tail of the costimulatory molecule CD2.4,18 In mature
T cells, this region is responsible for the direct interaction of CD2
with the intracellular adaptor CD2BP2, which is involved in signal
transduction.19 Additional molecules interact with the CD2 CT tail
through distinct proline-rich domains, including the CD2BP1
adaptor, implicated in actin polymerization and T-cell adhesion,
motility, and activation20-22; and CMS and CIN85, 2 members of
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the CMS/CIN85 adaptor family shown to regulate cytoskeletal
rearrangements and T-cell polarization.23,24
We show in this study that, besides the conserved CD2-like
proline-rich sequence, the human pT CT domain carries a
polyproline-arginine sequence that fits the atypical recognition
consensus recently reported for SH3 domains of the CIN85/CMS
family of adaptors.25,26 This sequence mediates binding of CIN85/
CMS adaptors to multiple signaling molecules, including the CD2
coreceptor in T cells,23 and regulates multiple functions in different
cell types,27 suggesting a role in pre-TCR function as well. We
provide evidence that the polyproline motif identified here in the
pT CT tail is in fact an indispensable binding site for CIN85/CMS
adaptors involved in pre-TCR signaling. Therefore, our data
identify CIN85/CMS proteins as the first known intracellular
adaptors of human pT required for pre-TCR function.
Materials and methods
Cell lines and transfections
The TCR-deficient Jurkat mutant JR3.11,28 SupT1 pre-T cells,29 and
COS7 cells were grown in RPMI 1640 (BioWhittaker, Verviers, Belgium)
plus 10% fetal calf serum (FCS; Gibco, Carlsbad, CA). Electroporations
were performed using a Gene Pulser II (Bio-Rad, Hercules, CA) as
described.15
cDNA constructs
cDNAs encoding human CIN85 or CMS were amplified by polymerase
chain reaction (PCR) from thymocyte cDNA. PCR products were cloned
into either the pcDNA3-Flag or the pcDNA3-HA vector. Flag-tagged CMS
and CIN85/CD2BP3 truncated forms were generated by PCR using
CMS-Flag and CIN85-Flag, respectively. GST (glutathione S-transferase)
fusion proteins for the full-length pT CT domain (GST-pT), or for the
truncated proline-rich Pro1 and Pro2 pT mutants (GST-pTPro1,
GST-pTPro2) were PCR-amplified using a pcDNA3-pT vector15 and
cloned into pGEX-4T1 (Amersham Biosciences, Arlington Heights, IL).
The GST-pTPro3 construct generated from the GST-pT construct was
subcloned into pGEX-4T3 (Amersham Biosciences). Green fluorescent
protein (GFP)–tagged CMS constructs (CMS-GFP, SH3ABC-GFP, and
C-term–GFP) generated by PCR using CMS-Flag were subcloned into
pEGFP-N1 (BD Biosciences, Palo Alto, CA). Cloned constructs were DNA
sequenced. Specific primer combinations used are shown in Table S1
(available on the Blood website; see the Supplemental Materials link at the
top of the online article).
GST fusion proteins and GST binding assays
GST fusion proteins were affinity-purified using glutathione-Sepharose
beads (Amersham Biosciences). COS7 cells were transiently transfected
with either Flag- or HA-tagged CIN85 or CMS constructs, lysed in
phosphate-buffered saline (PBS) containing 1% Triton X-100 (Sigma-
Aldrich, St Louis, MO), protease inhibition cocktail (Roche, Indianapolis,
IN), 1 mM PMSF, and 50 mM NaF, and incubated with GST fusion proteins
coupled to gluthatione-Sepharose beads. Bound proteins were resolved by
SDS-PAGE under reducing conditions. Immunoblotting was performed
using anti-Flag (M2; Sigma-Aldrich) or anti-HA (12CA5; Roche) monoclo-
nal antibodies (mAbs) plus horseradish peroxidase–anti-mouse IgG (Jack-
son Immunoresearch, West Grove, PA).
Immunoprecipitations and immunoblotting
SupT1 cells transfected with CMS-Flag were lysed in 0.3% Brij96V
(Sigma-Aldrich) buffer. Immunoprecipitation was performed as described16
with a polyclonal rabbit antibody against the human pT cytoplasmic
domain,15 and immunoblotting was performed with anti-Flag. JRpTWT-
and JRpTPro1-transduced cells were subjected to immunoprecipitation
and immunoblotting using anti-Flag. Western immunoblotting of endoge-
nous CMS and transfected Flag-tagged CMS and CMS-SH3ABC forms
was performed with anti-CMS/CD2AP (H-290; Santa Cruz Biotechnology,
Santa Cruz, CA) and anti-Flag, respectively.
Retroviral infections and flow cytometry
JR3.11 cells were transduced as described30 using the MigR1.1-GFP
retroviral bicistronic vector31 encoding Flag-tagged full-length pTWT or
pTPro1. Primer combinations used for subcloning are described in Table
S1. Sorted GFP-transduced cells were stained with an anti-CD3 (UCHT1)
mAb plus APC–anti-mouse Igs (BD Biosciences) and analyzed in a
FACSCalibur (BD Biosciences). Background staining was determined with
an irrelevant isotype-matched mAb plus APC–anti-mouse Igs.
Thymocyte subset isolation and Northern blotting
Postnatal thymocytes were isolated from thymus samples of patients aged
1 month to 3 years after informed consent and approval by the Consejo
Superior de Investigaciones Cientı´ficas (CSIC) Review Board was pro-
vided. The following cell subsets were isolated from the very same thymus
sample by Percoll (Amersham Pharmacia Biotech, Piscataway, NJ) density
fractionation and AutoMacs (Miltenyi Biotec, Bergisch Gladbach, Ger-
many) sorting:30,32 pre-–selected (CD4 CD8 CD3), pre-TCR (CD4
CD8 CD3 TCR), post-–selected (CD4 CD8 CD3), double-
positive (DP) TCR (CD4 CD8 CD3), and single-positive (SP)
TCR (CD3 CD4 or CD8). Total RNA (10 g) was resolved by
formaldehyde-agarose gel electrophoresis and blotted onto nitrocellulose
membranes (Zeta-Probe B; Bio-Rad). Hybridization was performed as
described.33
Confocal microscopy
SupT1 cells transiently transfected with CMS-GFP, SH3ABC-GFP, or
C-term–GFP were seeded onto poly-L-lysine (Sigma-Aldrich)–precoated
coverslips, and fixed with 4% paraformaldehyde for 30 minutes at room
temperature (RT). Labeling with phalloidin-TRITC (Sigma-Aldrich), phal-
loidin-Alexa647 (Invitrogen, Carlsbad, CA), anti-CD63 (Developmental
Studies Hybridoma Bank, Iowa City, IA), anti-EEA1, and anti-Lamp1 (BD
Biosciences) was performed in the presence of 0.05% saponin (Sigma-
Aldrich). Secondary antibodies included FITC–anti-IgG2a (Southern Bio-
technology, Birmingham, AL), Alexa555–anti-mouse IgGs, Alexa647–
anti-IgG1, Alexa555-IgG1, and Alexa488–anti-FITC (Invitrogen).
For pre-TCR activation, cells were incubated with anti-CD3 plus
Alexa555–anti-mouse IgGs on ice, washed, and incubated for 2 minutes at
37°C prior to fixation. Pre-TCR stimulation with anti-CD3–coated mag-
netic beads (Dynabeads; Dynal, Oslo, Norway) was performed for 5 or
15 minutes at 37°C (1:1 ratio) prior to fixation. To analyze pT internaliza-
tion, cells were incubated with an anti-pT mAb10 for 15 minutes at 37°C,
washed, and fixed or incubated for additional 15 minutes at 37°C prior to
fixation. Confocal microscopy was performed in a Radiance 2000 confocal
microscope (Bio-Rad) coupled to an Axiovert S100TV inverted microscope
(Zeiss, Oberkochen, Germany) using Methamorph 6.1R6 software (Univer-
sal Imaging, Downingtown, PA). Images are single XY sections extracted
from a Z-series of optical sections recorded at 0.5-m intervals (63/1.4
oil Plan-Apochromat objective).
Ca2 mobilization assay
JR3.11-transduced cells were loaded with 2 g/mL Indo-1 AM (Molecular
Probes, Eugene, OR) in cell loading medium (Hanks balanced salt solution
[HBSS] containing 1 mM each CaCl2 and MgCl2 and 1% FCS) for
30 minutes at 30°C in the dark. Washed cells were incubated in cell loading
medium for 5 minutes at 37°C, and 510-nm (FL4 channel) and 400-nm
(FL5 channel) emissions were analyzed in a FACSCVantage SE Cell Sorter
(BD Biosciences) at different time points both before and after stimulation
with anti-CD3. Ionophore (Sigma-Aldrich) treatment was used to control
for cell viability and intact calcium stores. The data were processed for
calculating the FL4/FL5 emission ratio using the Three Star FlowJo
software (BD Biosciences).
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NFAT transcriptional activation assay
JR3.11-transduced cells were transfected with a luciferase reporter plasmid
containing 3 tandem copies of the composite NFAT/AP1-response element
from the human IL-2 gene promoter, together with a pRL-CMV Renilla
reporter construct (Promega, Madison, WI), as described.34 After 24 hours,
cells were cultured for 6 hours with or without plate-bound anti-CD3 or
anti-pT mAbs and lysed using the Dual luciferase assay Kit (Promega).
Firefly luciferase and Renilla luciferase activities were determined in
duplicates. The luciferase activity was normalized by the Renilla luciferase
activity and expressed as fold-induction relative to the basal activity seen in
nonstimulated cells.
Results
CIN85 and CMS interact with the cytoplasmic domain of human
pT through different SH3 domains
Besides the reported CD2-like proline-rich sequence (Figure 1A;
Pro2) that is reiterated in mouse, the human pT CT domain was
found to carry 2 additional proline-based sequences: a C-term
noncanonical proline-rich sequence (LPPPL; Pro3), and a polypro-
line-arginine sequence (SPRPQPR; Pro1) placed directly upstream
of Pro2 (Figure 1A), which fits the PX(P/A)XXR or PXXXPR
recognition consensus of CIN85/CMS SH3 domains identified in
multiple signaling molecules.25,26 CIN85 and CMS adaptors share a
similar structure with 3 SH3 domains in the amino end, a central
proline-rich region, and a C-term coiled-coil domain27 (Figure 1B).
A third member of the family, CD2BP3, is a CIN85 isoform which
lacks the first SH3 domain due to an alternative splicing.24,27
To investigate whether CIN85/CMS adaptors physically inter-
act with human pT, a GST-pT fusion protein containing the pT
CT domain (GST-pT) was used in pull-down assays of COS7
cells transfected with Flag-tagged full-length CIN85, CMS, or
CD2BP3 proteins. Immunoblotting with anti-Flag revealed that
both CIN85 and CMS specifically associate with the CT tail of pT
(Figure 1C), while interaction of CD2BP3 was hardly detected (see
“Recruitment of multiprotein complexes involving CMS, CIN85,
and CD2BP3 adaptors to the cytoplasmic domain of the human
pT chain”). Next, CMS and CIN85 binding to pT was assessed
in vivo in SupT1 pre-T cells, which naturally express physiologic
levels of surface pre-TCR.15 Immunoprecipitations carried out with
an anti-pT tail antibody15 after transfection with CMS-Flag
confirmed that CMS was specifically coimmunoprecipitated with
pT from nonstimulated SupT1 cells at low amounts, as expected
from the low surface pre-TCR expression levels (Figure 1D), and
similar CMS levels were observed upon anti-CD3 activation (not
shown). Therefore, CMS specifically associates both in vitro and in
vivo with the CT tail of human pT. Equivalent experiments failed
to reveal a CIN85-pT association in vivo, even under activating
conditions (data not shown), suggesting that CIN85 has a weaker
affinity for pT than CMS in SupT1 pre-T cells.
To identify the specific CIN85/CMS domains involved in pT
binding, GST-pT pull-downs were performed using Flag-tagged trun-
cated forms of either CIN85 or CMS (Figure 2A,B, respectively).
CIN85-SH3ABC and CIN85-SH3AB truncated proteins were precipi-
tated with GST-pT at higher amounts than full-length CIN85 (Figure 2C;
Figure 1. In vitro and in vivo interactions of CIN85/CMS adaptors with the
human pT cytoplasmic tail. (A) Proline-rich motifs within the cytoplasmic domain
of human pT. (B) Domain organization of CMS, CIN85, and CD2BP3 members of
the CIN85/CMS adaptor family. (C) CMS and CIN85 interact in vitro with the human
pT cytoplasmic domain. Cell lysates from COS7 cells transfected with Flag-tagged
CMS or CIN85 were pulled-down with a GST fusion protein of the pT tail (GST-pT)
or with GST alone. Immunoblotting was carried out with an anti-Flag mAb. (D) CMS
interacts in vivo with the human pT cytoplasmic domain. Total-cell lysates of SupT1
cells transfected with Flag-tagged CMS or with an empty vector were immunoprecipi-
tated with a rabbit antibody against the human pT cytoplasmic tail or with
preimmune rabbit serum (NRS), and analyzed by Western blotting with anti-Flag.
Data are representative of at least 3 independent experiments. Vertical lines have
been inserted to indicate a repositioned gel lane.
Figure 2. CMS and CIN85 interact with the polyproline-arginine sequence
within the human pT tail through different SH3 domains. Schematic representa-
tion of Flag-tagged CIN85 (A) and CMS (B) forms used in pull-down assays shown in
panels C and D, respectively. Pull-down assays were performed with GST fusion
proteins of either the wild-type pT cytoplasmic tail (GST-pT) or the indicated
proline-rich deletion mutants (GST-pTPro1, GST-pTPro2, and GST-pTPro3).
Precipitated proteins were analyzed by Western blotting with an anti-Flag mAb. Data
are representative of at least 3 independent experiments. Vertical lines have been
inserted to indicate a repositioned gel lane.
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lanes 1-3). However, no binding of CIN85-SH3BC and neither of the
CIN85 forms lacking the SH3AB N-terminal (N-term) region was
detected (Figure 2C; lanes 4-6), suggesting that the SH3A domain is
essential for specific interaction of CIN85 with the pT tail. Accordingly,
CD2BP3 bound very inefficiently to pT (see “Recruitment of multipro-
tein complexes involving CMS, CIN85, and CD2BP3 adaptors to the
cytoplasmic domain of the human pT chain”; Figure 3A). In contrast to
CIN85, full-length CMS was coprecipitated with pT more efficiently
than the CMS-SH3ABC truncated form (Figure 2D; lanes 1-2), and at
higher amounts than full-length CIN85 (compare Figure 2D, lane 1 with
Figure 2C, lane 1). No binding of the C-term CMS fragment lacking the
SH3 domains was observed (Figure 2D; lane 5), and deletion of either the
SH3C or SH3A domains also abolished the interaction of the remaining
SH3 domains (Figure 2D; lanes 3-4), suggesting that both SH3C and
SH3A are simultaneously required for pT binding. Although we cannot
formally exclude that the folding of the truncated proteins could account
for the observed results, as a whole, our data suggest that CIN85 and CMS
bind to pT through different SH3 domains, as previously reported for
binding to other proteins such as Cbl.24
Identification of the specific CIN85/CMS SH3 binding motif in
the human pT cytoplasmic tail
To confirm the identity of the polyproline sequence/s in the human
pT tail responsible for the interaction with CIN85/CMS SH3
domains, pull-downs were next performed using GST-fused pT
tail mutant forms (pTPro1-3) that lacked each of the
3 polyproline sequences shown in Figure 1A. We found that neither
the distal C-term (Pro3) nor the CD2-like (Pro2) proline-rich pT
motifs were required for CIN85/CMS binding (Figure 2C,D). In
contrast, deletion of the polyproline-arginine (Pro1) motif com-
pletely impaired the association of pT to CIN85 and CMS (Figure
2C,D), indicating that Pro1 is a bona fide motif for CIN85 and CMS
SH3 binding. As a whole, these data provide evidence that
interaction of CIN85/CMS SH3 domains with the human pT
cytoplasmic tail specifically involves the Pro1 polyproline-arginine
motif, and identify human pT as a novel CIN85/CMS interacting
partner.
Recruitment of multiprotein complexes involving CMS, CIN85,
and CD2BP3 adaptors to the cytoplasmic domain of the human
pT chain
According to lack of SH3A, CD2BP3 was hardly precipitated with
GST-pT, even under overexpression conditions (Figure 3A).
Since CMS and CD2BP3 can heterodimerize through their coiled-
coil domains,27 it is possible that CMS-CD2BP3 heterodimers
could be recruited to pT. Confirming this possibility, CD2BP3
was coprecipitated with CMS in a dose-dependent manner from
COS7 cells transfected with CMS and increasing amounts of
CD2BP3 (Figure 3B). Similar experiments performed using HA-
tagged CIN85 and Flag-tagged CD2BP3 showed that CD2BP3 was
also coprecipitated with CIN85 bound to pT (Figure 3C).
Therefore, both CMS and CIN85 can mediate the recruitment of
CD2BP3 to the pT CT domain. Finally, GST-pT pull-downs
performed in COS7 cells transfected with CMS, CD2BP3, and
increasing amounts of CIN85 revealed that CIN85 did not impair
binding of CMS to pT, nor CD2BP3 recruitment (Figure 3D). In
contrast, amounts of CMS and CD2BP3 coprecipitated with pT
increased in the presence of CIN85 in a dose-dependent manner
(Figure 3D). As a whole, we can conclude that multiprotein
complexes involving CMS, CIN85 and CD2BP3 adaptors can be
recruited to the CT domain of the human pT chain, likely owing
to hetero-oligomerization mediated by their coiled-coil domains.
Differential regulation of CIN85/CMS gene expression during
human thymic development
It has been reported that some CIN85/CMS adaptors are transcrip-
tionally regulated during the development of particular tissues and
organs in which they are functionally involved.35 To assess the
regulation of CIN85/CMS transcription in vivo during human
thymocyte development, gene expression was analyzed by North-
ern blotting at discrete intrathymic stages surrounding pre-TCR–
mediated -selection (Figure 4A).33 As shown in Figure 4B,
transcription of the 3 members of the CIN85/CMS family was
differentially regulated along human thymopoiesis. Measurements
of the relative mRNA amounts normalized to -actin transcripts
from 2 independent experiments (Figure 4C) indicated that transcrip-
tion of CIN85 and CD2BP3 splicing isoforms remained essentially
constant throughout development. In contrast, CMS transcription
was transiently up-regulated following pre-TCR expression: it
increased up to 4.0-fold from pre- to post- selected pre-T cells,
and thereafter it returned to basal levels at the SP stage. SupT1
pre-T cells included as a pre-TCR control also displayed rela-
tively increased expression of CMS (Figure 4C). These results
indicate that CMS transcription is specifically up-regulated in
pre-T cells following pre-TCR expression, suggesting a role for
Figure 3. Multiprotein complexes involving CMS, CIN85, and CD2BP3 can be
recruited to the cytoplasmic domain of human pT. Total lysates from COS7 cells
transfected with the indicated amounts of CD2BP3-Flag (A) or CMS-Flag and
CD2BP3-Flag (B) were subjected to pull-down with GST-pT. Precipitated proteins
were analyzed by Western blotting with an anti-Flag mAb. COS7 cells were
transiently cotransfected with the indicated amounts of CD2BP3-Flag and CIN85-HA
(C) or CD2BP3-Flag, CMS-Flag, and CIN85-HA (D). Total-cell lysates and proteins
precipitated with GST-pT were analyzed by immunoblotting using either an
anti-Flag mAb to detect CD2BP3 and CMS (top 2 panels) or an anti-HA mAb to detect
CIN85 (bottom 2 panels). *Nonspecific band recognized by the anti-HA antibody.
Data are representative of at least 3 independent experiments. Vertical lines have
been inserted to indicate a repositioned gel lane.
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CMS in pre-TCR function. Alternatively, since up-regulated CMS
was also observed in DP thymocytes, CMS could be involved in
attenuation of pre-TCR signaling in post- selected thymocytes.
CMS colocalizes with the actin cytoskeleton to the pT
endocytic pathway
To get some insights into the function of CMS, we first assessed its
subcellular distribution using SupT1 pre-T cells expressing GFP-
tagged CMS. Confocal microscopy analysis showed that CMS-
GFP expression was mostly confined to cytosolic vesicular struc-
tures that fully colocalized with polymerized actin (Figure 5A).
Actin-rich vesicles were present as well in vivo in primary human
pre-TCR thymocytes (Figure S1A), but not in mature T cells, in
which CMS showed a diffuse expression throughout the cytosol
(Figure S1B), as reported for murine T cells.36 These data suggest
that formation of CMS/actin-rich vesicles is constitutive and pre-T
cell specific. Since CMS contains 4 acting-binding domains in its
C-term region,27 we next assessed whether the C-term is respon-
sible for the association of CMS to the actin cytoskeleton in the
vesicles found in pre-T cells. We found that overexpression of a
GFP-tagged truncated form of CMS involving the 3 SH3 domains
(SH3ABC) altered the vesicular pattern and prevented the colocal-
ization of CMS to the actin cytoskeleton, this resulting in a diffuse
intracellular distribution of GFP. In contrast, formation of CMS/
actin-rich vesicles was conserved when a C-term CMS mutant
lacking the SH3ABC domains was overexpressed (Figure 5A).
Therefore, the C-term domain is responsible for the vesicular
distribution and the colocalization of CMS with polymerized actin
Figure 4. Differential regulation of CIN85/CMS transcription during human
thymic development. (A) Scheme of the developmental progression of human
intrathymic stages. (B) Total RNA from the indicated cell subsets was analyzed for
CIN85/CMS/CD2BP3 transcription by Northern blotting. Blots were simultaneously
hybridized with CIN85 and CMS probes, and sequentially rehybridized with pT,
TCR, and -actin probes. Purity of cell subsets was greater than 95% upon flow
cytometric reanalysis, except for the pre-TCR subset, which included up to 10% of
DP TCR thymocytes (faint TCR band). (C) Amounts of CMS, CIN85, and
CD2BP3 transcripts were normalized to -actin mRNA values. Relative transcrip-
tional levels displayed in arbitrary units are referred to the pre- cell stage. Data
represent the means plus or minus SEM of 2 experiments corresponding to
independent thymus samples. Vertical lines have been inserted to indicate a
repositioned gel lane.
Figure 5. CMS colocalizes with the actin cytoskeleton to the pT endocytic
pathway. (A) SupT1 pre-T cells were transfected with GFP-tagged versions of either
full-length CMS, a truncated CMS form encompassing the SH3ABC domains, or a
C-term CMS mutant lacking the SH3 domains. Transfected cells were labeled with
phalloidin-TRITC and analyzed by confocal microscopy for the coexpression of
polymerized actin (F-actin) and GFP. (B) SupT1 CMS-GFP transfectants were
labeled with anti-EEA1, anti-CD63, or anti-Lamp1 mAbs followed by Alexa555–anti-
mouse IgGs. Coexpression of CMS-GFP with EEA1, CD63, or Lamp1 was analyzed
by confocal microsopy. (C) SupT1 CMS-GFP transfectants were incubated with an
anti-pT mAb for 15 at 37°C, washed, and fixed. After fixation, internalized pT was
detected by labeling with Alexa555–anti-mouse IgGs. Colocalization to the lysosomal
compartment was determined by confocal microscopy after labeling with anti-Lamp1
plus Alexa647–anti-IgG1. Data are representative of at least 3 independent
experiments.
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found in pre-T cells. Inmunofluorescence analyses performed to
assess the identity of the constitutive CMS/actin-rich vesicles
formed in pre-T cells (Figure 5B) revealed that GFP-CMS partly
colocalized with the early endosomal compartment marker EEA1
and with CD63, which marks late endosomes and lysosomes,37 but
colocalization with the lysosomal marker Lamp1 was hardly found
(mean colocalization percentage 	 SEM: 26.2 	 1.3, 30.5 	 2.2,
and 15.9 	 2.1, respectively). These data indicate that CMS
localizes constitutively to the endocytic compartment, but is mostly
excluded from the lysosomal compartment in pre-T cells.
Since pre-T cells are able to internalize and degrade the
pre-TCR in an autonomous manner,16,17 it is possible that CMS/actin-
rich vesicles participate in constitutive endocytosis of the pre-TCR.
To investigate whether CMS vesicles do actually contain internal-
ized pre-TCR proteins, the constitutive fate of surface pre-TCR
complexes was monitored over time in nonstimulated CMS-GFP–
expressing Sup-T1 cells fixed at various times after labeling with
an anti-pT mAb.10 Confocal microscopy analysis showed that the
pT chain was efficiently internalized within the first 15 minutes
(Figure 5C). By this time, a major fraction of labeled pT (up to
55%) colocalized to CMS-rich vesicles, and a minor proportion
(less than 30%) colocalized with Lamp1 lysosomes, from which
CMS was excluded. Over time, increasing proportions of pT
localized to lysosomes (up to 70% within 30 minutes; Figure S2),
but CMS and Lamp1 colocalization was difficult to observe (data
not shown), confirming that CMS and pT colocalize exclusively
at the endocytic compartment. Notably, neither CMS nor polymer-
ized actin colocalized with the conventional TCR complex
internalized upon receptor engagement on mature T cells (Figure
S3), supporting a selective role for the CMS endocytic pathway in
pre-T cells. As a whole, these results indicate that CMS colocalizes
with polymerized actin to the pT endocytic pathway, and marks
pT trafficking to lysosome degradation. Accordingly, disruption
of the actin cytoskeleton by cytochalasin D treatment abrogated
pT transport to lysosomes in pre-T cells and resulted in the
accumulation of pT in early endosomes (Figure S2).
CMS-rich clusters colocalize with polymerized actin at the site
of pre-TCR activation
In mature T cells, interaction of CMS with the CD2 coreceptor is
involved in CD2 clustering and cytoskeletal reorganization follow-
ing CD2 ligand attachment.23 We thus assessed whether CMS
participates in pre-TCR patterning following pre-T cell activation.
As shown in Figure 6A, CD3 engagement of CMS-GFP–
transfected SupT1 cells resulted in the redistribution and clustering
Figure 6. CMS and the actin cytoskeleton are simulta-
neously recruited to the site of pre-TCR activation.
Confocal microscopy analysis of (A) CMS-GFP–
transfected SupT1 cells stained with an anti-CD3 mAb
plus Alexa555–anti-mouse and left at 4°C (top row), or
incubated at 37°C for 2 minutes to induce pre-TCR
aggregation (bottom row); or (B) CMS-GFP transfectants
either untreated (top row) or stimulated with anti-CD3–
coated beads for 5 and 15 minutes (middle and bottom
rows) and stained with phalloidin-TRITC. Data are repre-
sentative of at least 3 independent experiments.
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of the pre-TCR on the cell surface. Notably, CMS-rich clusters
appeared at the area of pre-TCR engagement and colocalized with
the pre-TCR. To confirm that CMS is recruited to the site of
pre-TCR activation, the fate of CMS was then monitored over time
in SupT1 cells fixed at various times after pre-TCR stimulation
with anti-CD3–coated magnetic beads (Figure 6B). Recruitment
of CMS-GFP to the zone of pre-TCR engagement was efficiently
induced within the first 5 minutes of stimulation. Phalloidin
staining revealed the redistribution and clustering of the actin
cytoskeleton to the same area and its colocalization with CMS. In
addition, CMS and polymerized actin fully colocalized in cytosolic
vesicles that accumulate over time at the zone of tight contact of the
pre-T cell with the stimulatory bead (35% vs 57% and 27% vs 48%
at 5 vs 15 minutes, respectively, in 2 different experiments; Figure
6B). As shown for nonstimulated pre-T cells, these CMS-rich
vesicles expressed early and/or late endosomal markers, but not
lysosomal markers (data not shown). As a whole, these results
indicate that signaling through the pre-TCR induces the simulta-
neous recruitment of CMS and polymerized actin to the site of
pre-TCR clustering, and their colocalization to the pre-TCR
endocytic pathway.
Binding of CMS to the proline-arginine motif in the human pT
cytoplasmic tail is involved in pre-TCR signaling
It has been shown that activation through the murine pre-TCR
promotes Ca2-dependent signals.8 To investigate whether the
CIN85/CMS binding motif of human pT is involved in pre-TCR
signaling, Ca2 mobilization was assessed after pre-TCR cross-
linking in TCR-deficient Jurkat cells (JR3.11)28 in which Flag-
tagged versions of either a wild-type or a Pro1 mutant pT chain
were coexpressed with GFP by retroviral transduction. Anti-Flag
immunoprecipitations of GFP sorted cells showed comparable
levels of expression of the wild-type and mutant pre-TCRs (Figure
7A), and equivalent surface expression was observed as well by
flow cytometry (Figure 7B). Also, western immunoblotting with
anti-CMS revealed similar expression levels of endogenous CMS
(Figure 7A). As shown previously in pre-T cells,8,10 CD3 crosslink-
ing of JR3.11 cells that expressed wild-type pT induced a [Ca2]i
rise, which consisted of an initial rapid rise followed by a slow
decrease. However, Ca2 mobilization was markedly defective in
JR.311 cells bearing the mutant pTPro1 chain (Figure 7C),
indicating that the proline-arginine CIN85/CMS binding motif is
required for proper pre-TCR signaling.
Since intracellular Ca2 rise is necessary for pre-TCR–induced
activation of the NFAT transcription factor,8 we next assessed the
functionality of the NFAT transcriptional pathway in JRpTWT
and JRpTPro1 cells using a luciferase reporter assay.34 As
shown in Figure 7D, pre-TCR crosslinking with an anti-pT mAb
promoted a marked luciferase increase in JRpTWT cells, while
NFAT activity was significantly lower in JRpTPro1 mutants.
Notably, overexpression of a truncated CMS form encompassing
exclusively the SH3ABC domains (Figure 7E) significantly en-
hanced pre-TCR–mediated NFAT transcriptional activity in
JRpTWT cells, while this effect was prevented in pTPro1
mutants (Figure 7F), supporting the theory that SH3ABC-
promoted NFAT activation depends on pT binding. In contrast,
overexpression of either the entire CMS molecule (Figure 7E) or a
CMS C-term form lacking the SH3 domains (not shown) markedly
reduced NFAT transcriptional activity in both JRpTWT and
pTPro1 cells (Figure 7F), thus revealing a dominant-negative
role for CMS on NFAT activation independent of pT binding.
However, overexpressed CMS did not significantly affect Ca2
mobilization in JRpTWT cells (Figure S4), thus precluding a
dominant negative role of CMS on Ca2 mobilization. As a whole,
our results showing that binding of CMS SH3 domains to the
proline-arginine motif of pT is in fact relevant for pre-TCR
signaling provide the first molecular evidence for a cytosolic
adaptor of the pT chain involved in pre-TCR function.
Discussion
Current views support that the exclusive capability of the pre-TCR
complex in promoting T-cell development maps to the CT domain
of its pT chain.7,18 It is thus expected that pT interacts with
intracellular adaptors that propagate specific pre-TCR signals;
therefore, identification of such regulators is key for understanding
the unique signaling properties of the pre-TCR. However, identifi-
cation of pT interacting partners has remained elusive. Here, we
provide biochemical evidence that members of the CIN85/CMS
family of adaptors are cytosolic interactors of human pT. Binding
of CIN85/CMS to the pT CT domain did not involve the reported
CD2-like proline-rich sequence conserved in mouse pT.4,18
Rather, we identified a novel polyproline-arginine (SPRPQPR)
sequence, which fits the atypical recognition consensus for binding
of CIN85/CMS adaptors,25,26 and show that this sequence is indeed
a bona fide binding site for CIN85/CMS SH3 domains in human
pT. Supporting the functional relevance of this interaction, we
show that pre-TCR activation results in the simultaneous recruit-
ment of CMS and the actin cytoskeleton to the site of pre-TCR
clustering. In addition, CMS was found to associate with polymer-
ized actin via its C-term region, colocalizing in the endocytic
pathway with pT molecules in traffic to the lysosomal compart-
ment. These observations, together with the finding that deletion of
the pT CIN85/CMS-binding motif impaired pre-TCR–mediated
Ca2 mobilization and NFAT transcriptional activity, and precluded
enhanced activation induced by overexpression of a CMS-SH3
N-term form, provide compelling evidence that CMS acts down-
stream of the pre-TCR to promote appropriate pre-TCR signaling.
Biochemical studies addressing CMS-pT interaction could not be
performed in a more physiological condition due to the scarce
numbers of primary pre-T cells, thus limiting the extension of our
results to thymocyte development. However, we do provide
evidence that the pT polyproline-arginine domain identified here
endows the human pre-TCR with a specific SH3-binding site,
critical for interaction with intracellular adaptors involved in
pre-TCR function.
Despite high sequence identity of CIN85 and CMS SH3
domains, CMS bound to pT more efficiently than CIN85, which
concurs with the observation that distinct SH3 domains of CIN85
and CMS were involved in pT interaction. Since CIN85 but not
CMS SH3 domains interact with proline-rich sequences within the
same molecule,24 it was expected that full-length CIN85 interacted
with pT less efficiently than its SH3ABC and SH3AB forms.
Besides this form of biochemical regulation, our data suggest that
transcriptional regulation is an additional mechanism operating
during T-cell development to favor binding of CMS to pT in
pre-TCR cells, and support a preferential function for CMS versus
CIN85 and CD2BP3 in pre-T cells.
In mature T cells, CMS and CIN85 play a pivotal role in the
regulation of cytoskeletal rearrangements and T-cell polariza-
tion.23,24 Binding of CMS and its mouse ortholog CD2AP to CD2
facilitates membrane receptor clustering and cytoskeletal polariza-
tion, which enable organization of the immunologic synapse (IS)
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and TCR-mediated signaling.23,24,38 Attempts to analyze similar
morphologic and molecular events associated to pre-TCR activa-
tion have been hampered by the fact that the pre-TCR signals
constitutively in a ligand-independent manner. By modeling pre-
TCR activation with anti-CD3–coated beads,10,39 we show here
that pre-TCR clustering and recruitment of polymerized actin and
CMS to the site of pre-TCR activation are downstream events of
pre-TCR activation. CMS recruitment was apparently independent
of the pT CMS-binding site (not shown), but proper pre-TCR
signaling, as measured by Ca2 mobilization, was contingent on
CMS binding to an intact pT polyproline-arginine domain.
Similarly, TCR clustering and IS formation can occur in CMS/
CD2AP-deficient T cells, or upon CD2-independent T-cell activa-
tion, while TCR-mediated signal transduction is defective in
both situations, mainly due to profound alterations in large-scale
molecular segregation at the IS.23,36,40 Therefore, as proposed for
the CMS/CD2AP-CD2 interaction,23 the function of the CMS-pT
interaction could be to promote a central cluster of pre-TCR
complexes that could maintain a stable domain required for
sustained pre-TCR signaling. In this scenario, either pTmultimer-
ization induced by interaction of the 3 SH3 domains of a single
CMS molecule to distinct pT chains, or CMS multimerization
mediated by a single pT molecule,41 could also be predicted. An
additional level of organization could significantly contribute to
pre-TCR clustering, since hetero-oligomers involving CMS, CIN85,
and CD2BP3 can be synergistically associated to pT. Thus, it can
Figure 7. Binding of CMS to the pT cytoplasmic tail
is involved in pre-TCR signaling. (A) Expression levels
of pre-TCR (TCR-pT) heterodimers and pT mono-
mers in JR3.11 cells transduced with Flag-tagged ver-
sions of either pTWT or pTPro1 were detected by
anti-Flag immunoprecipitation, followed by nonreducing
SDS-PAGE, and Western blotting with an anti-Flag mAb.
Endogenous CMS expression was detected by inmmuno-
blotting with anti-CMS. (B) Surface expression levels of
pre-TCR complexes on pTWT and pTPro1 JR3.11
GFP-transduced cells were analyzed by flow cytometry
with an anti-CD3 mAb. (C) Time-course response in
calcium mobilization obtained from the indicated cell
lines after stimulation with an anti-CD3 mAb. Ionophore
treatment was used to control for cell viability and intact
calcium stores. Data are represented as the FL4/FL5
ratio of emission analyzed by flow cytometry at the
indicated times. Data are representative of at least
4 independent experiments. (D) Deletion of the Pro1
motif (Pro1) of the human pT tail impairs pre-TCR–
induced NFAT transcriptional activity. pTWT and
pTPro1 JR3.11 cells transiently transfected with an
NFAT–luciferase-reporter plasmid were stimulated with
an anti-pT mAb or left unstimulated. NFAT transcrip-
tional activity is expressed as the fold increase of lucif-
erase activity above levels obtained from the nonstimu-
lated control in a representative experiment (left), or as
the mean (	 SEM) of relative NFAT activity of 6 indepen-
dent experiments (right); *P 
 .005. (E) Western blot
analysis of CMS expression in pTWT and pTPro1
JR3.11 cells. Total lysates of cells transfected with an
empty vector, or with a vector encoding either full-length
CMS or a CMS truncated form encompassing the
SH3ABC CMS domains, were analyzed by immnubloting
with anti-CMS or anti-Flag. (F) CMS modulates preTCR-
induced NFAT transcriptional activity. pWT and
pTPro1 JR3.11 cells were transfected with either an
empty vector, or a vector encoding either full-length CMS
or a CMS truncated form encompassing the SH3ABC
CMS domains. NFAT transcriptional activity was ana-
lyzed upon stimulation with anti-pT as the mean
(	 SEM) of relative NFAT activity of 4 independent
experiments. *P 
 .001 and **P 
 .05.
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be proposed that CMS acts as a scaffolding molecule that enables
pre-TCR clustering required for propagation of autonomous cell
signaling.
Besides the role of SH3 domains in mediating CMS-pT
interactions, the C-term region of CMS was shown to mediate
CMS association with the actin cytoskeleton and CMS localization
to the pT endocytic pathway. It is thus possible that CMS
participates in the regulation of endosomal vesicle formation in
pre-T cells, as proposed in other cells.42 Our results also suggest a
functional role for CMS in pT trafficking to lysosomal degrada-
tion, which could finally result in attenuation of pre-TCR signaling.
This possibility is strongly supported by the finding that CMS is
up-regulated during thymocyte development in post-–selected
thymocytes. However, so far we have failed to provide evidence
that the CMS-pT interaction directly participates in pre-TCR
internalization and/or degradation, although such a role could
depend on an indirect association of CMS mediated through c-Cbl,
as has been reported for other signaling receptors, including EGFR
and TCR.40,43 It has recently been shown that the impaired ability of
CD2AP/CMS-deficient T cells to degrade the activated TCR
indirectly resulted from an impaired receptor activation, suggesting
that CMS-mediated receptor clustering may finally balance TCR
signaling and degradation.40 A similar CMS-dependent mechanism
could finally regulate pre-TCR signaling and degradation, but an
additional level of complexity can be expected considering that the
proline-rich region of CIN85/CMS acts as an interaction module
for SH3-containing signaling proteins, such as the p85 PI3K
subunit, Grb2, or Src kinases,27 involved in T cell (and likely, pre-T
cell) signaling. As a result, distinct parts of the CMS molecule
could elicit divergent functional activities, whose interplay could
finally determine the pre-TCR signaling output. According to this
view, the SH3ABC CMS domains behave as constitutively active
CMS forms upon binding to the proline-arginine motif of pT,
while full-length CMS markedly impaired SH3ABC-induced NFAT
activation. Since the inhibitory effect of CMS was independent of
pT interaction, and involved the C-term portion of the molecule
(data not shown), it could result from the specific binding and
sequestration of molecular effectors, downstream of Ca2 mobili-
zation, involved in NFAT transactivation and pre-TCR signaling.
The dominant-negative effect of CMS could also reflect an active
role of the molecule in promoting and unbalance toward pT
degradation. Therefore, it is possible that distinct parts of the CMS
molecule may differentially affect particular functions whose
interplay and coordination finally determine pre-TCR signaling
output.
While unraveling the molecular basis of CMS-mediated pre-
TCR signaling will require further studies, our results provide the
first molecular evidence that the CT domain of pT provides the
pre-TCR with the unique capacity to recruit CIN85/CMS adaptors
crucial for propagation of downstream signals. Therefore, as
previously proposed, the cytoplasmic tail of pT could confer on
the pre-TCR the capacity to “costimulate,”4 while self-oligomeriza-
tion of pT would be the mechanism responsible for initiation of
ligand-independent pre-TCR signaling.12 Both signals, however,
are delivered separately via engagement of the TCR and the
costimulatory molecule CD2 in mature T cells.
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